Cargando…
Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-κB Signaling Pathway in Rheumatoid Arthritis
OBJECTIVE: To explore the role of B cells in rheumatoid arthritis (RA) and the potential effects and mechanisms of etanercept on B cells. METHODS: In RA patients, the levels of tumor necrosis factor-α (TNF-α) and B cell activating factor (BAFF) were detected by ELISA. The percentage of B cell subset...
Autores principales: | Cai, Xiao-Yu, Zhu, Yue, Wang, Chen, Tang, Xiao-Yu, Han, Le, Shu, Jin-Ling, Zhang, Xian-Zheng, Liang, Fa-Qin, Ge, Jing-Ru, Xu, Li, Mei, Dan, Zhang, Ling-Ling, Wei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235293/ https://www.ncbi.nlm.nih.gov/pubmed/32477138 http://dx.doi.org/10.3389/fphar.2020.00676 |
Ejemplares similares
-
Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis
por: Goëb, Vincent, et al.
Publicado: (2005) -
TRAF6 neddylation drives inflammatory arthritis by increasing NF-κB activation
por: Liu, Kewei, et al.
Publicado: (2019) -
AQP4 Attenuated TRAF6/NFκB Activation in Acrylamide-Induced Neurotoxicity
por: Hung, Chia-Yu, et al.
Publicado: (2022) -
Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007) -
Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)